other names for tirzepatide Tirzepatide for Weight Loss Mounjaro, Zepbound, and Tirzepatide: Understanding

The FDA indication split and what it means for claims When the FDA approved Mounjaro in May 2022 for type 2 diabetes, the billing pathway was relatively simple

FAQs You must have a BMI over 30 or meet other health criteria

Zepbound is administered as a once-weekly subcutaneous injection, with an initial dose of 2.5 mg and maintenance doses ranging from 5 mg to 15 mg

Makers of these drugs recommend having a conversation about the side effect profile and personalized risks with a healthcare professional before starting

Milligrams are absolute

Shared decision-making ensures that your treatment plan aligns with your goals, preferences, and individual medical circumstances